Available at: Aldawsari, M., Almadani, F.A., Almuhammadi, N., Algabsani, S., Alamro, Y
Connect the Dots on What Works Track weight trends, log symptoms, and upload progress photos
[76] found no evidence of increased risk of suicidal ideation and self-injury associated with GLP-1 RAs compared to SGLT-2 inhibitors in individuals with T2DM and obesity, based on data from the Valencia Health System Integrated Database (VID) (per-protocol analysis: HR, 1.04
When you take GLP-1 medications, they bind to the same receptors in the brain that the natural hormone does, signaling a feeling of fullness and satisfaction